The Development and Testing of a Chemotherapy-Induced Phlebitis Severity (CIPS) Scale for Patients Receiving Anthracycline Chemotherapy for Breast Cancer

被引:6
|
作者
Harris, Valerie [1 ]
Hughes, Meinir [1 ]
Roberts, Rosie [1 ]
Dolan, Gina [2 ]
Williams, E. Mark [2 ]
机构
[1] Velindre Canc Ctr, Velindre Rd, Cardiff CF14 2TL, Wales
[2] Univ South Wales, Fac Life Sci & Educ, Pontypridd CF37 1DL, M Glam, Wales
关键词
chemical phlebitis; anthracycline; breast cancer; phlebitis scale; chemotherapy; EPIRUBICIN;
D O I
10.3390/jcm9030701
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A chemotherapy induced phlebitis severity (CIPS) scale was developed in patients receiving anthracycline chemotherapy for breast cancer. A five-point severity scoring scale for chemotherapy-induced phlebitis was tested for inter-rater reliability. Ease of use was observed through timing assessments and a review of the completeness of documentation. A comparison of CIPS scale grade with participant reported severity scores was made. The final version was tested for inter-rater reliability, with 122 patient assessments. There was an 89.3% (109 of 122) agreement between the assessors (kappa = 0.82, SE +/- 0.042, 95% CI 0.74-0.90). Mean time to complete the scale was 1 min 36 s and documentation was fully completed for 98% of assessments. Patient reported severity closely matched the CIPS grade (kappa = 0.54, SE +/- 0.045, 95% CI 0.46-0.63). This new scale provides a list of symptoms associated with chemotherapy phlebitis, which can be scored quickly and accurately. It provides a reliable method for assessing chemotherapy-induced phlebitis, enabling a better understanding of its impact on patients' quality of life, and to inform the appropriate choice of peripheral or central intravenous administration. Multicentre testing of the CIPS scale is recommended.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Chemotherapy-Induced Neutropenia in Breast Cancer Patients Receiving Sequential Anthracycline and Taxane Chemotherapy: An institutional experience
    Staudigl, C.
    Seifert, M.
    Tea, M-K
    Pfeiler, G.
    Fink-Retter, A.
    Fritzer, N.
    Singer, C. F.
    CANCER RESEARCH, 2012, 72
  • [2] Identifying Risk Factors for Anthracycline Chemotherapy-induced Phlebitis in Women with Breast Cancer: An Observational Study
    Roberts, R.
    Borley, A.
    Hanna, L.
    Dolan, G.
    Ganesh, S.
    Williams, E. M.
    CLINICAL ONCOLOGY, 2021, 33 (04) : 230 - 240
  • [3] The Prevalence of Chemotherapy-induced Arrhytmia in Breast Cancer Patients Receiving Chemotherapy Regimen
    Probokusumo, Jagaddhito
    Hartopo, Anggoro Budi
    Anggraeni, Vita Yanti
    Kusumastuti, Dyah Adhi
    Mumpuni, Hasanah
    Hardianti, Mardiah Suci
    Purwanto, Ibnu
    Hutajulu, Susanna Hilda
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0F) : F66 - F66
  • [4] The development of a prediction tool for chemotherapy-induced anemia in breast cancer patients receiving adjuvant chemotherapy.
    Dranitsaris, G
    Clemons, M
    Verma, S
    Vincent, M
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S106 - S106
  • [5] Predictors of chemotherapy-induced severe anemia in cancer patients receiving chemotherapy
    Razzaghdoust, Abolfazl
    Mofid, Bahram
    Peyghambarlou, Parvin
    SUPPORTIVE CARE IN CANCER, 2020, 28 (01) : 155 - 161
  • [6] Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy
    Hirotoshi Iihara
    Hironori Fujii
    Chiaki Yoshimi
    Maya Yamada
    Akio Suzuki
    Nobuhisa Matsuhashi
    Takao Takahashi
    Kazuhiro Yoshida
    Yoshinori Itoh
    International Journal of Clinical Oncology, 2016, 21 : 409 - 418
  • [7] Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy
    Iihara, Hirotoshi
    Fujii, Hironori
    Yoshimi, Chiaki
    Yamada, Maya
    Suzuki, Akio
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Yoshida, Kazuhiro
    Itoh, Yoshinori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 409 - 418
  • [8] Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients
    Cho, J.
    Choi, E. K.
    Kim, I. R.
    Im, Y. H.
    Park, Y. H.
    Lee, S.
    Lee, J. E.
    Yang, J. H.
    Nam, S. J.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 346 - 351
  • [9] Predictors of chemotherapy-induced severe anemia in cancer patients receiving chemotherapy
    Abolfazl Razzaghdoust
    Bahram Mofid
    Parvin Peyghambarlou
    Supportive Care in Cancer, 2020, 28 : 155 - 161
  • [10] Chemotherapy-induced Neutropenia in Breast Cancer Patients who receive Anthracycline and Taxane sequentially
    Staudigl, C.
    Anker, B.
    Fink-Retter, A.
    Singer, C. F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (04)